FDA Reopens Comment Period for Drug-Induced Liver Injury Guidance and Announces Public Conference

Summary

The FDA is reopening the comment period for its draft guidance on drug-induced liver injury until June 30, 2008, and is hosting a public conference to discuss the guidance and gather additional input. The conference is cosponsored by the FDA, AASLD, and PhRMA.